Development and evaluation of drugs : from laboratory through licensure to market /

Development and evaluation of drugs : from laboratory through licensure to market /

Saved in:

Bibliographic Details
Main Author:	Lee, Chi-Jen
Other Authors:	Lee, Lucia H., Lu, Cheng-Hsiung
Format:	Book
Language:	English
Published:	Boca Raton : CRC Press, c2003.
Edition:	2nd ed.
Subjects:	Drug development. Drugs > Testing. Drugs > Law and legislation > United States. Pharmaceutical industry.
Online Access:	View in OPAC
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Marketing research of the national antiarrhythmic drugs market
by: T. P. Zarichna, et al.
Published: (2019-08-01)

PHARMACEUTICAL DEVELOPMENT OF DRUGS FOR PEDIATRIC PRACTICE: FUNDAMENTAL BASES AND SPECIFIC FEATURES
by: I. A. Narkevich, et al.
Published: (2019-01-01)

ANALYSIS OF INDUSTRIAL PRACTICE OF DRUG QUALITY RISK MANAGEMENT IN RUSSIAN PHARMACEUTICAL ENTERPRISES
by: A. B. Kashirina, et al.
Published: (2021-03-01)

MULTIPLE VIEW MARKETING ANALYSIS OF THE RUSSIAN PLANT-BASED DRUGS MARKET
by: A. V. Akamova, et al.
Published: (2019-01-01)

Slowly Learning the Hard Way: U.S. America’s War on Drugs And Implications for Mexico
by: Glen Olives Thompson
Published: (2014-12-01)

Non-profit drug research and development: the case study of Genethon
by: Szymon Jarosławski, et al.
Published: (2019-01-01)

E.U. veterinary drug’s legislation
by: Cristina, T. Romeo
Published: (2008-06-01)

Comparative Analysis of the United States’ War on Drugs Policy in Mexico and Colombia: Failure and Success Factors
by: Renitha Dwi Hapsari, et al.
Published: (2023-10-01)

Past, current and future of legal regulation of drugs compounding in the Russian Federation
by: D. D. Mamedov, et al.
Published: (2023-11-01)

SOME ASPECTS OF THE MARKETING STUDIES FOR THE PHARMACEUTICAL MARKET OF ANTIVIRAL DRUGS
by: A. G. Salnikova, et al.
Published: (2015-12-01)

THE ANALYSIS OF THE ACTIVITIES OF THE CENTERS FOR THE DEVELOPMENT OF DRUGS, CREATED ON THE BASIS OF EDUCATIONAL ORGANIZATIONS
by: A. A. Semin, et al.
Published: (2019-01-01)

RELASI SISTEM MANAJEMEN LINGKUNGAN ISO 14001 DAN KINERJA KEUANGAN
by: Memed Sueb, et al.
Published: (2012-03-01)

CLUSTER ANALYSIS OF INTEGRATED “DRUG SUPPLY” CONCEPT
by: G. S. Barkaev, et al.
Published: (2022-07-01)

The war against regulation : from Jimmy Carter to George W. Bush /
by: Cooper, Phillip J.
Published: (2009)

Investigation of Pharmaceutical Developments in Fars Province in Iran during the First Pahlavi Period
by: Somaiyeh Marghoub Khajeh, et al.
Published: (2025-05-01)

Analysis of the effectiveness of regulatory legal acts on counterfeiting of medicines in Ukraine
by: S. O. Lebed, et al.
Published: (2021-03-01)

« Trafiquant de drogue » : mirages et usages d’une catégorie sociale
by: Sabine Guez
Published: (2019-12-01)

CONTENT-ANALYSIS OF THE RUSSIAN MARKET OF SELECTIVE α2-ADRENOMIMETIC MEDICINAL DRUGS, APPLIED IN THERAPY OF RHINITIS OF DIFFERENT ETIOLOGY
by: L. V. Ganicheva, et al.
Published: (2017-05-01)

RESULTS OF IMPORT SUBSTITUTION ANALYSIS OF ANTI-CANCER MEDICATIONS IN THE RUSSIAN FEDERATION (2013–2018)
by: O. A. Ryzhova, et al.
Published: (2019-05-01)

Comparative Analysis of the QbD Approach in the Pharmaceutical Industry
by: S. A. Rozhnova, et al.
Published: (2019-11-01)

Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available
by: F. V. Gorkavenko, et al.
Published: (2019-07-01)

Harnessing Artificial Intelligence in Drug Discovery: Transformative Approaches and Future Directions
by: Damini Dilip Salunke, et al.
Published: (2025-05-01)

Cuba, United States and fight against drug trafficking: ups and downs of a necessary cooperation
by: Santiago E. Bejerano
Published: (2021-07-01)

Can <i>Caenorhabditis elegans</i> Serve as a Reliable Model for Drug and Nutraceutical Discovery?
by: Opeyemi. O. Deji-Oloruntoba, et al.
Published: (2025-05-01)

TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-03-01)

Is a Drug Allergy in a Patient’s History Real? Our Experience with Diagnostic Drug Provocation Tests
by: Begum Gorgulu Akin, et al.
Published: (2025-02-01)

Cases and Materials on the Law of Oil and Gas /
by: Williams, Howard R.
Published: (1979)

STUDY OF PHARMACEUTICAL SPECIALISTS’ INFORMATION AWARENESS ON THE MATTERS OF DRUG ABUSE
by: N. Yu. Porseva, et al.
Published: (2021-05-01)

The relevance of creating a new combined ophthalmic drug with anti-inflammatory and antibacterial effects
by: L. I. Kucherenko, et al.
Published: (2025-07-01)

Unraveling the artificial intelligence role in drug discovery and pharmaceutical product design: an opportunity and challenges
by: Bhakti Sudha Pandey, et al.
Published: (2025-05-01)

Interchangeability of Fluconazole Drugs
by: N. D. Bunyatyan, et al.
Published: (2018-12-01)

ORGANIZATION OF PHARMACEUTICAL AID IN SOLVING THE PROBLEM OF EXCESS WEIGHT IN THE POPULATION
by: G. Ya. Ibragimova, et al.
Published: (2017-12-01)

Some aspects of liposomal oxaliplatin formulations
by: A. V. Stadnichenko, et al.
Published: (2015-02-01)

Façonner la prescription, influencer les médecins
by: Jérôme Greffion, et al.
Published: (2015-06-01)

Bioprinting for drug screening: A path toward reducing animal testing or redefining preclinical research?
by: Harshavardhan Budharaju, et al.
Published: (2025-09-01)

Examining drug poisoning in child and adolescent psychiatric patients: clinical analysis and pharmacy services
by: Yuwen Wang, et al.
Published: (2025-07-01)

International comparison of generic competition, prices, and usage trends: South Korea and G20 countries
by: Da Hye Lee, et al.
Published: (2025-05-01)

Significance of herbal drugs legislation for their rational use
by: Cupara Snežana M., et al.
Published: (2009-01-01)

The introduction of new technologies and financial support for the innovational pharmaceutical industry in the veterinary medicine sector based on the development of priority areas of the Ukrainian regions
by: I. V. Bushuieva, et al.
Published: (2019-12-01)

REFERENCE STANDARDS OF ACTIVE INGREDIENTS OF POTENT ANALGESIC DRUGS
by: A. V. Sosnov, et al.
Published: (2019-01-01)